TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 2:58 · $NEWLIMIT · Epigenetic reprogramming startup advances first pre-clinical candidate for liver disease
episode briefing
Kleiner Perkins

The Science of Pausing and Reversing Aging | Laura Deming and Jacob Kimmel

2026-02-17 · 2 company · 6 thematic
sentiment
2 bull0 bear0 neu
speakers
laura deming

Founder of a stealth cryopreservation company developing reversible organ vitrification and hibernation pods; previously ran a longevity-focused venture fund for over a decade.

jacob kimmel

Co-founder of NewLimit, developing epigenetic reprogramming medicines to reset aged cells; background in aging biology research since teenage years.

quote
“We treat time slightly differently. Um, so we are working on developing medicines that reprogram the epiggenome... And we're trying to reset the epiggome back to what it's like when you're young. So, ideally restoring youthful function in…”
—jacob kimmel

episode shorts · 4

Restoring an Aging Cell

The Coolest Decade to Build Deep Tech

What Is a Virtual Cell?

Building a Faster Way to Cure Disease

now playing · $NEWLIMIT
$INTEL-CRYObullish· high· poslaura deming
Cryopreservation startup achieves reversible rat kidney vitrification, targets organ banking
Reversible cryopreservation via vitrification and nanoparticle-mediated rewarming solves the organ transplant logistics bottleneck and could enable whole-body hibernation for term…
$NEWLIMITbullish· high· posjacob kimmel
Epigenetic reprogramming startup advances first pre-clinical candidate for liver disease
AI-driven discovery of transcription factor combinations resets epigenetic age in multiple cell types, with a first pre-clinical candidate targeting liver disease and pipeline exp…